Target Audience:
The primary target audience for the ACC is general ophthalmologists and cornea specialists practicing in comprehensive and cornea subspecialty work settings.


Learning Objectives:

Following completion of this activity, participants should be able to:

1.     Describe the surgical techniques, advantages, limitations, and potential complications of new advances in corneal, ocular surface, and anterior segment surgical procedures.

2.     Describe a comprehensive clinical management strategy, taking an evidence-based approach in the treatment of inflammatory, allergic, infectious, immunologic, and neoplastic diseases involving the cornea and anterior segment.

3.     Describe new information relating to clinical billing, malpractice issues, EMR integration, and staff performance evaluation guidelines.

4.     Survey new and emerging technological developments in corneal evaluation that would assist in the overall diagnosis and management of corneal and other anterior segment diseases.

5.     Integrate knowledge from new technological developments in corneal, clinical testing modalities that assist in the overall assessment of the ocular disease processes.

6.     Demonstrate enhanced ability to manage challenging corneal and ocular surface diseases.

7.     Participate effectively in the pre-operative and post-operative management of the patient, and identify novel intra-operative surgical techniques in the management of various corneal, ocular surface, and anterior segment diseases.

8.     To understand the indications, identify appropriate candidates, learn various new and useful surgical techniques in amniotic membrane transplantation.

9.     To familiarize the current concepts in various corneal diseases including, but not limited to the following: corneal collagen cross-linking, post-LASIK ectasia, PTK applications, scleral and pericardial grafts, and tectonic lamellar keratoplasty.


Educational Need/ Closing the Gap:

Knowledge gaps are a given with any practicing general ophthalmologist and cornea specialist due to the relative inability of the busy practitioners to be fully aware of the vast-expanding, and rapidly-changing knowledge base that is propelled by technological advances that seem to have recently exploded in the otherwise dormant cornea domain, that is further complimented with new surgical techniques such as DMEK moving rapidly to soon capture the center stage of corneal transplantation. ACC 2014 is programmed to meet these continuing educational needs in the corneal arena by bringing together a group of leading corneal experts to expand and educate on all aspects of medical and surgical cornea as listed below:

·      Corneal infection, inflammation, and ulceration

·      Medications, preservatives, diagnostic testing, and contact lenses

·      Ocular surface, dry eye, immunology, and allergy

·      Scleritis, tumors, dystrophies, and corneal ectasia

·      Office corner – Malpractice issues, EMR, performance evaluation, billing in 2014, and ethics

·      Contact lens-related infections, trauma, Vitamin A, nutritional supplements, corneal inlays, post-LASIK and 
        post-PRK ectasia

·      Advances in pterygium surgery, stem cell transplantation, and surgical management of OCP

·      Comprehensive, must-know, ocular surface surgical techniques, and anterior segment reconstruction

·      How to transition to DMEK, and DSAEK corneal transplantation

·      Artificial cornea – Boston keratoprosthesis

·      Amniotic membrane transplantation

·      Tectonic lamellar and therapeutic keratoplasty

·      Scleral and pericardial grafts, and PTK applications in corneal diseases

·      Corneal collagen crosslinking

Ophthalmologists and cornea specialists who attend ACC 2014 will depart as experts in the field of medical and surgical cornea. Continuing medical education ensures physicians maintain the level of awareness needed to provide the highest quality of corneal care for each of their patients such that their eyesight is protected and the final quality of vision is maximized.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller, Pentavision and MCME Global. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation
Dannemiller designates this live activity for a maximum of 15 AMA PRA Category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity


Dannemiller and PentaVision, LLC fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Maureen Platt at by March 1, 2014 in order to receive service.


All faculty and non-faculty disclosures will be provided during the meeting.